Execs predict rebound at Rx services business

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p13
Trade Publication
The article reports on the forecasts of the executives at CVS Caremark Corp. which stresses that the pharmacy services segment will rebound in fiscal 2012 in the U.S.


Related Articles

  • Company is poised for strong finish to current fiscal year.  // Chain Drug Review;12/8/2014, Vol. 36 Issue 20, p84 

    The article reports that the U.S-based retailer and health care company CVS Health Corp. is forecasted for strong finish in fiscal year 2014.

  • Despite recent hiccup, PBM has great potential.  // Chain Drug Review;12/7/2009, Vol. 31 Issue 21, p56 

    The article reports that CVS Caremark's Pharmacy Benefits Management unit based in New York has a great potential as a future growth catalyst for the company, despite of the uneven performance and recent contract losses of the company.

  • Analysts Surprised by Guidance.  // MMR;2/21/2011, Vol. 28 Issue 4, p8 

    The article presents a business forecast for CVS Caremark Corp. in Woonsocket, Rhode Island.

  • Analysts still bullish on growth outlook.  // Chain Drug Review;12/7/2009, Vol. 31 Issue 21, p56 

    The article focuses on the financial analysts forecast on the business performance of CVS Caremark Corp. in 2010, stating that the company will continue to drive share gains, with its industry-leading retail same-store sales growth and its unique competitive advantage from merger.

  • No slowdown seen for surging retail business.  // Chain Drug Review;12/7/2009, Vol. 31 Issue 21, p56 

    The article reports that the retail market sales of New York-based CVS Caremark Corp. show no slowdown for company's surging retail business due to its ongoing expansion and acquisition of Longs Drug Stores.

  • Outlook for Year Revised Upward.  // MMR;11/28/2011, Vol. 28 Issue 18, p24 

    The article forecasts the financial performance of CVS Caremark Corp. in Woonsocket, Rhode Island, with earnings per share expected to range from 2.57 dollars to 2.61 dollars.

  • Market Opportunities.  // Research;6/1/2009, Vol. 32 Issue 6, p74 

    The article presents analyzes from financial analysts on the financial performance and trends for CVS Caremark Corp., Kraft Foods Inc. and Kellogg Co. Andrew Lazar of Barclays Capital sees -10% deflation on unhedged bases for Kraft while for Kellogg, he sees several factors for the improving...

  • Profit, revenue outlook raised following robust performance.  // Chain Drug Review;8/17/2009, Vol. 31 Issue 14, p15 

    The article reports on the move of CVS Caremark Corp. to raise its full-year revenue and earnings outlook for 2009 in Woonsocket, Rhode Island. David Rickard, chief financial officer of the company, explains that the outlook was raised due to the company's strong performance. The company expects...

  • Future is healthy for PBM business. ALEXANDER, ANTOINETTE // Drug Store News;10/15/2012, Vol. 34 Issue 13, p26 

    The article reports on the projected success of CVS Caremark Corp.'s pharmacy benefit management (PBM) in the U.S. CVS projected that its PBM will have increased limited networks interest and will obtain a probable one to three percent savings. According to CVS Caremark Pharmacy Services...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics